Back to Search
GUIDO MARCUCCI, M.D.
M.D.
Hematology (Internal Medicine) Physician
NPI: 1689689127IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology (Internal Medicine) PhysicianPrimary
Internal Medicine — Hematology
Code: 207RH0000X
35072976(OH)C134913(CA)
Medical Oncology Physician
Internal Medicine — Medical Oncology
Code: 207RX0202X
35072976(OH)C134913(CA)
CMS Specialties
PrimaryHEMATOLOGY
Education
OTHER
Class of 1986
Research & Publications (20)
Prognostic significance of, and gene and microRNA expression signatures associated with, CEBPA mutations in cytogenetically normal acute myeloid leukemia with high-risk molecular features: a Cancer and Leukemia Group B Study.
PMID 18809607·J Clin Oncol·2008
8-other
MicroRNA expression in cytogenetically normal acute myeloid leukemia.
PMID 18450603·N Engl J Med·2008
8-other
High expression levels of the ETS-related gene, ERG, predict adverse outcome and improve molecular risk-based classification of cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B Study.
PMID 17577018·J Clin Oncol·2007
8-other
Bioavailability of azacitidine subcutaneous versus intravenous in patients with the myelodysplastic syndromes.
PMID 15831784·J Clin Pharmacol·2005
3-trial
Overexpression of the ETS-related gene, ERG, predicts a worse outcome in acute myeloid leukemia with normal karyotype: a Cancer and Leukemia Group B study.
PMID 16275934·J Clin Oncol·2005
8-other
Phase I study of oblimersen sodium, an antisense to Bcl-2, in untreated older patients with acute myeloid leukemia: pharmacokinetics, pharmacodynamics, and clinical activity.
PMID 15824414·J Clin Oncol·2005
3-trial
Molecular heterogeneity and prognostic biomarkers in adults with acute myeloid leukemia and normal cytogenetics.
PMID 15604894·Curr Opin Hematol·2005
6-review
Prognostic factors and outcome of core binding factor acute myeloid leukemia patients with t(8;21) differ from those of patients with inv(16): a Cancer and Leukemia Group B study.
PMID 16110030·J Clin Oncol·2005
8-other
Core binding factor (CBF) acute myeloid leukemia: is molecular monitoring by RT-PCR useful clinically?
PMID 12930314·Eur J Haematol·2003
6-review
Phase 1 and pharmacodynamic studies of G3139, a Bcl-2 antisense oligonucleotide, in combination with chemotherapy in refractory or relapsed acute leukemia.
PMID 12393493·Blood·2003
3-trial
Understanding the molecular basis of imatinib mesylate therapy in chronic myelogenous leukemia and the related mechanisms of resistance. Commentary re: A. N. Mohamed et al., The effect of imatinib mesylate on patients with Philadelphia chromosome-positive chronic myeloid leukemia with secondary chromosomal aberrations. Clin. Cancer Res., 9: 1333-1337, 2003.
PMID 12684391·Clin Cancer Res·2003
6-review
Quantification of CBFbeta/MYH11 fusion transcript by real time RT-PCR in patients with INV(16) acute myeloid leukemia.
PMID 11455976·Leukemia·2001
8-other
Molecular and clinical advances in core binding factor primary acute myeloid leukemia: a paradigm for translational research in malignant hematology.
PMID 11107447·Cancer Invest·2000
6-review
Allogeneic stem cell transplantation for patients with relapsed chemorefractory aggressive non-hodgkin lymphomas.
PMID 19361746·Biol Blood Marrow Transplant·2009
8-other
A novel recessive mutation of fibroblast growth factor-23 in tumoral calcinosis.
PMID 19411468·J Bone Joint Surg Am·2009
5-case
Quantification of regional DNA methylation by liquid chromatography/tandem mass spectrometry.
PMID 19442645·Anal Biochem·2009
8-other
Prognostic importance of MN1 transcript levels, and biologic insights from MN1-associated gene and microRNA expression signatures in cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study.
PMID 19451432·J Clin Oncol·2009
8-other
Epigenetic changes during disease progression in a murine model of human chronic lymphocytic leukemia.
PMID 19666576·Proc Natl Acad Sci U S A·2009
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 300 W 10TH AVE
COLUMBUS, OH 43210 - Phone
- (614) 293-8619
Quick Facts
- NPI
- 1689689127
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 4
- Locations
- 2
- Years in Practice
- 40
- Publications
- 20
Are you this provider?
Claim Your Profile